The SMARTS-UP Graduate Schools programme at Université Paris Cité aims to promote the internationalisation of Master’s programmes and facilitate the integration of top students into international organisations, creating a pool of excellence for the recruitment of future PhD candidates.

Application 2024-2025

In this context, it is proposed to fund outgoing mobility scholarships for 2024-2025, amounting to €1,000 per month, for all Graduate School students wishing to undertake an internship abroad for 1 to 6 months.

Regarding travel expenses, the SMARTS-UP Graduate Schools project offers:

  • If you travel within Europe: €200
  • If you travel outside Europe: up to €1,000

Eligibility criteria

  • Be a Master’s student (M1 or M2) at one of Université Paris Cité’s Graduate Schools and enrolled at Université Paris Cité in 2024-2025.
  • Undertake an internship abroad ending no later than August 31, 2025.

Required documents

  • Download and complete the application form
  • A half-page summary of the mobility project
  • Recommendation letter from the Master’s supervisor
  • Support letter from the host organisation
  • Copy of the student card

How to Apply?

Application opening date: November 1, 2024
Application closing date: November 30, 2024 at midnight (CET)
Applicants will be informed of the decision by email in January 2025.

Fill out the form and send it to smarts-up.mobility@u-paris.fr

Read more

New Circle U. online courses available!

New Circle U. online courses available!

The year is drawing to a close and the Circle U. European Alliance, of which Université Paris Cité is a member, is sharing its latest online courses with you. Take advantage of the festive season to sign up for one of these modules and enhance your knowledge and...

read more
Phages, Towards a Targeted Alternative to Antibiotics

Phages, Towards a Targeted Alternative to Antibiotics

With the rapid development of antibiotics in the 1930s, phage therapy – using viruses known as bacteriophages or phages to tackle bacterial infections – fell into oblivion. But as the current rise in antibiotic resistance is making it increasingly difficult to treat...

read more